Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

Focusing prostate cancer testing on men at highest risk of developing the disease is likely to improve the ratio between benefits and the harms of screening, suggests a paper published today in BMJ.

Regularly eating certain dietary fats, including animal fats, was associated with greater all-cause mortality in men with nonmetastatic prostate cancer, a cohort study suggested. Among nearly 4,900 ...

Prostate cancer is the most common type of cancer, and it’s often treated with great success. That’s the good news for the tens of thousands of men in D.C., Maryland and Virginia who are likely to be ...

What we choose to call cancer may shape patients’ behavior in ways that influence their health outcomes. Relabeling low-grade prostate cancer as a precancerous condition, for instance, could reduce ...

Prostate cancer, one of the deadliest forms of cancer for men in the United States and worldwide, is on the decline, according to new research. Researchers looked at World Health Organization data ...

An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...

Please provide your email address to receive an email when new articles are posted on . Improved screening and treatments could reverse global prostate cancer mortality trends. Involving other ...

May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six months before and after prostate surgery improved the chances of eliminating the cancer and ...

A multi-institutional collaborative study led by researchers at the University of Chicago and the Fred Hutchinson Cancer Center has identified a previously unknown biological mechanism that controls ...

A preliminary study of 52,330 Israeli women found similar rates of heart attack, stroke, blood clots and early death among hormone therapy users and nonusers, though it cannot prove safety. Older ...

People who lived alone had a significantly higher mortality from cancer and multiple other conditions. (American Cancer Society) The FDA warned Amgen that a promotional video for ...